GDS Holdings Limited ADS GDS reports blowout Q4 2025 EPS results 55 percent year over year revenue growth minor stock gain
ZBH Zimmer Biomet Holdings Inc reports Q4 2025 earnings per share that align perfectly with Wall Street consensus estimates
MDXH MDxHealth SA Ordinary Shares Q4 2025 revenue grows 198 percent year over year shares rise 176 percent despite EPS miss
VYNE Therapeutics Inc VYNE beats Q4 2025 EPS expectations significantly yet shares edge slightly lower in todays trading
Stocks Climb as Oil Retreats and Dollar Weakens on Iran Diplomacy Optimism
SpaceX Starship Faces Technical Challenges in Race for Lunar Mission Milestones
EOG Resources Surges in Q1 Key Drivers Behind the Energy Stocks Rally
Bitcoin Drops to 745k Poised for Weekly Loss Amid Geopolitical Tensions
South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest
SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags
SRXH Q2 2025 Earnings EPS Loss of 074 Amidst Stock Decline
FIS Q1 2026 Earnings EPS Surpasses Estimates by 464 as Stock Moves Lower
SSM Q1 2026 Earnings Loss per Share of 059 as PreRevenue Development Continues
CVI Q1 2026 Earnings Deep Losses and Wide Miss Signal Challenging Refining Environment
PTCT Q1 2026 Earnings Narrower Loss Surprises Estimates as Stock Dips Slightly
Sabesp SBS Edges Lower Analyzing Support and Resistance Levels Amidst Modest Decline
Bgin Blockchain BGIN Slides 359 Key Support Level Tested
Heron Therapeutics HRTX Slides to 086 as Selling Pressure Persists
Cardinal Health CAH Holds Steady Near Key Support After Slight Decline
STRD Preferred Stock Holds Steady Near 7350 as Support and Resistance Levels Come into Focus
Sensex Stocks with up to 40 Upside Potential Analysts Identify Key Names
Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline
CapsoVision Inc CV Advances 118 as Price Moves Toward Resistance